Using a Population Pharmacokinetic Model to Estimate the Dosage of Teicoplanin in Patients With Hematologic Malignancy or Critical Illness
- Status
- NOT_YET_RECRUITING
- Phase
- N/A
Clinical Trials Related to Hematological Malignancies
Related studies linked through entity extraction aliases.
Long-term Follow-up of Participants Treated With Galapagos Chimeric Antigen Receptor (CAR) T-cell Therapies
- Status
- RECRUITING
- Phase
- PHASE3
National Longitudinal Cohort of Hematological Diseases (NICHE) - CART
- Status
- RECRUITING
- Phase
- N/A
Feasibility of the Use of Weighted Blankets to Improve Sleep Among Patients With Hematological Malignancies
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- NA
Drug Response Profiling (DRP) Registry Zurich for Hematological Malignancies
- Status
- RECRUITING
- Phase
- N/A
A Clinical Study of HMPL-506 in Patients With Hematological Malignancies
- Status
- RECRUITING
- Phase
- PHASE1
Prognostic Value of "CD200" in Hematological Malignancies. Hematological Malignancies Comprise a Group of Malignant Clonal Disorders Arising From the Hematopoietic Tissues , Including Leukemia , Multiple Myeloma , and They Have a High Morbidity and Mortality
- Status
- NOT_YET_RECRUITING
- Phase
- N/A
Combination of ATG-based Conditioning Regimen and PTCy for GVHD Prevention in Allo-HSCT After PD-1 Blockade
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
M-2018-334 in Hematological Malignancies
- Status
- NOT_YET_RECRUITING
- Phase
- NA
A Study of DXC006 in Patients With Advanced Solid Tumors and Hematologic Malignancies
- Status
- RECRUITING
- Phase
- PHASE1
Allogeneic Immunotherapy of Hematological Malignancies Using Regulatory T-cell Selective Depletion
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1/PHASE2
Study of AZD9829 in CD123+ Hematological Malignancies
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Efficacy of Inhaled Aromatherapy on Nausea and Vomiting in Hematological Malignancies
- Status
- RECRUITING
- Phase
- NA
Correlation Between Gut Microbiota and Clinical Response to CAR-T Treatment for Hematological Malignancies
- Status
- UNKNOWN
- Phase
- N/A
Safety and Efficacy of SMART101 in Adult Patients With Hematological Malignancies After Haploidentical HSCT With Post-transplant Cyclophosphamide
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
The Study of ICP-248 in Patients With Mature B-cell Malignancies
- Status
- RECRUITING
- Phase
- PHASE1
APA and Relaxation by Biofeedback in Patients With Haematological Malignancy Admitted in ICU
- Status
- RECRUITING
- Phase
- NA
CD7 CAR-T for Patients With r/r CD7+ Hematologic Malignancies
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Nemtabrutinib (MK-1026) in China Participants With Relapsed or Refractory Hematologic Malignancies (MK-1026-005)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
A Study of ATG-018 (ATR Inhibitor) Treatment in Patients With Advanced Solid Tumors and Hematological Malignancies
- Status
- TERMINATED
- Phase
- PHASE1